UC AKT.ANL. 08/24 PAH3/ DE000HC8URE5 /
27/06/2024 13:46:31 | Var.-0.020 | Denaro14:21:17 | Lettera14:21:17 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
100.050EUR | -0.02% | 100.010 Quantità in denaro: 225,000 |
100.050 Quantità in lettera: 225,000 |
PORSCHE AUTOM.HLDG V... | 37.50 - | 23/08/2024 | Call |
GlobeNewswire
14:27
Aeroflow Health Launches Personalized Nutrition Services, Harnessing the Power of Food to Improve He...
GlobeNewswire
14:26
Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All ...
GlobeNewswire
14:18
Medicenna Therapeutics Reports Fiscal Year 2024 Financial Results and Operational Highlights
GlobeNewswire
14:15
The Chainsmokers and Bebe Rexha Headline The Challenge, Abercrombie & Fitch Co.’s Annual Festival an...
GlobeNewswire
14:13
Xylo Technologies: Charging Robotics Secures First Commercial Order for EV Wireless Charging Systems...
GlobeNewswire
14:12
Charging Robotics Secures First Commercial Order for EV Wireless Charging Systems in Automatic Car P...
GlobeNewswire
14:07
Global Study Finds Only 22% Effectively Using Gen AI Across All Business Functions
GlobeNewswire
14:05
Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer
GlobeNewswire
14:04
Noom Introduces AI-Enabled Products to Enhance On-Demand Health Care and Interactive Coaching
GlobeNewswire
14:03
American Rare Earths to Receive A$10.7 Million (US$7.1 Million) of Grant Funding from State of Wyomi...
GlobeNewswire
14:02
Dawn Bates, Founder of Dawn Bates International Reaches the Finals for the Social Impact Award in Na...
GlobeNewswire
14:01
Redwood Feeds Snak-King’s Appetite for Transportation Innovation Amid Supply Chain Disruption
GlobeNewswire
14:00
HYTN Awarded Drug Establishment License from Health Canada, Expanding GMP Capabilities
GlobeNewswire
14:00
As Consumers’ Monthly Debt Loads Increase, Auto Lenders Must Adapt to Manage Risk, Increase Originat...
GlobeNewswire
14:00
INmune Bio, Inc. Completes Blinded Interim Analysis of Phase II Alzheimer’s Disease Trial